Clinical Reviews in Allergy and Immunology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 11.5 | Q1 | 97.5% | 3.286 | Q1 | 98.0% |
| 2024 | 11.3 | Q1 | 97.4% | 3.163 | Q1 | 97.9% |
| 2023 | 8.4 | Q1 | 89.8% | 2.195 | Q1 | 96.2% |
| 2022 | 9.1 | Q1 | 87.5% | 2.391 | Q1 | 96.8% |
| 2021 | 10.8 | Q1 | 86.5% | 2.160 | Q1 | 96.4% |
| 2020 | — | — | 1.811 | Q1 | 94.6% | |
| 2019 | — | — | 1.759 | Q1 | 94.4% | |
| 2018 | — | — | 0.955 | Q1 | 83.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1559-0267
ISSN
1080-0549
country
UScoverage
1995-2026